Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
69%
ALSO IN IBBQ
IBBQ
207
HOLDINGS
16%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus IBBQ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 3.7% | 7.6% | 3.7% |
|
GILEAD SCIENCES INC | 3.7% | 7.4% | 3.7% |
|
AMGEN INC | 3.5% | 7.6% | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.4% | 5.5% | 3.4% |
|
BIOGEN IDEC INC | 3.8% | 2.1% | 2.1% |
FTXH Overweight Relative to IBBQ
|
ABBVIE INC | 7.5% |
|
JOHNSON & JOHNSON | 7.4% |
|
MERCK & CO. INC. | 7.2% |
|
PFIZER INC | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 6.4% |
|
ELI LILLY & CO | 3.9% |
|
CARDINAL HEALTH INC | 3.7% |
|
ZOETIS INC | 3.2% |
|
VIATRIS, INC. | 2.3% |
|
BIOGEN IDEC INC | 1.7% |
FTXH Underweight Relative to IBBQ
|
ALNYLAM PHARMACEUTICALS INC | -4.8% |
|
AMGEN INC | -4.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.9% |
|
GILEAD SCIENCES INC | -3.7% |
|
INSMED INC | -2.4% |
 |
ARGENX SE ADR | -2.2% |
|
REGENERON PHARMACEUTICALS | -2.1% |
|
SUMMIT THERAPEUTICS INC | -1.4% |
|
ROYALTY PHARMA PLC CLASS A | -1.4% |